NCT07629869Recruiting
COPD Flare-Up Clinic After Severe Exacerbations
The Role of COPD Flare-up Clinic Service After Severe Exacerbations to Reduce Recurrent Exacerbations
Source: ClinicalTrials.gov · Last updated 24 Sept 2026
Brief summary (registry, in English)
This prospective randomized controlled trial evaluates whether a specialized "COPD flare-up clinic service" improves outcomes in patients following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Patients presenting to the emergency department with AECOPD and discharged or hospitalized will be randomized 1:1 to either structured follow-up in a dedicated flare-up clinic or standard follow-up by scheduled telephone interviews. The researches hypothesize that structured follow-up in a specialized clinic will reduce recurrent exacerbations, optimize long-term COPD management, and improve patients' quality of life compared to standard care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- First submitted
- 1 Jun 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Diseases
- COPD
- NCT number
- NCT07629869
What you commit to
- Study type: Interventional
- Planned participants: 240
- From 1 Jul 2026 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Symptomatic heart failure as the main reason for emergency department visit in the last 6 months.
Other
- Uncontrolled comorbidity.
- Vulnerable Populations: To ensure ethical compliance and participant safety, the study will exclude vulnerable populations. This includes pregnant women, and any person lacking the mental or legal capacity to provide independent informed consent.
Who the study is looking for
- Prior COPD diagnosis based on clinical and spirometry accepted criteria.
- Acute exacerbation of COPD as the main reason for ED arrival.
- Ability to perform in-person and telephone follow-up.
- Agree to participate, with a signed informed consent.
Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906 Coordinator of this site? Confirm its status | Tel Aviv | Israel | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.